T-Cell/Histiocyte Rich Lymphoma

Explore clinical trials studying T-Cell/Histiocyte Rich Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

T-Cell/Histiocyte Rich Lymphoma trial results

Recruiting

NCT06544265

Conditions: Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
Locations: Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States

Winship Cancer Institute of Emory University Atlanta, Georgia, United States

The University of Kansas Cancer Center Fairway, Kansas, United States

Rutgers Cancer Institute New Brunswick, New Jersey, United States

Recruiting

NCT05544019

Conditions: ALK-Positive Large B-Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +66 more
Locations: Banner Health - MD Anderson Cancer Center Gilbert, Arizona, United States

Christiana Care Hospital - Helen F Graham Cancer Center Newark, Delaware, United States

Napa Research Pompano Beach, Florida, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View all 36 locations